Cargando…
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Psoriasis is a systemic immune-mediated disease associated with an increased risk of comorbidities, such as psoriatic arthritis, cardiovascular disease, metabolic syndrome, inflammatory bowel disease, psychiatric disorders, and malignancy. In recent years, with the advent of biological agents, the e...
Autores principales: | Jiang, Yuxiong, Chen, Youdong, Yu, Qian, Shi, Yuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837020/ https://www.ncbi.nlm.nih.gov/pubmed/36592323 http://dx.doi.org/10.1007/s40259-022-00569-z |
Ejemplares similares
-
Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis
por: Cai, Jiangluyi, et al.
Publicado: (2021) -
Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis
por: Feldman, Steven R., et al.
Publicado: (2015) -
Management of Moderate to Severe Psoriasis in Patients with Metabolic Comorbidities
por: Gisondi, Paolo, et al.
Publicado: (2015) -
Biological therapies in moderate and severe
psoriasis: perspectives and certainties
por: Constantin, MM, et al.
Publicado: (2014) -
Therapy of moderate and severe psoriasis
por: Claes, Christa, et al.
Publicado: (2006)